Under the terms of the Exclusive License, Radiance will pay CSPC an upfront payment of $15 million, and up to $150 million in potential development and regulatory milestone payments and over $1 ...

Alphamab Oncology has dosed the first subject in the randomised Phase III JSKN003-306 trial of its anti-human epidermal ...

with comparable response rates in patients previously treated with an ADC and/or CAR-T." Teclistamab, meanwhile, is a companion bispecific to Janssen's GPRC5DxCD3 drug talquetamab, which has also ...

Johnson & Johnson's much-touted crop of bispecific antibodies for cancer generated ... GlaxoSmithKline's first-to-market antibody-drug conjugate (ADC) Blenrep (belantamab mafodotin).

The addition of epcoritamab-bysp to standard chemotherapy significantly improved response and survival for patients with ...

In this article, we are going to take a look at where Agree Realty Corporation (NYSE:ADC) stands against the other dividend stocks. The majority of dividend-paying stocks distribute payouts on a ...

Zura Bio Limited (NASDAQ:ZURA – Get Free Report) has earned an average recommendation of “Buy” from the seven brokerages that ...

After hours: February 19 at 5:10:43 PM EST ...